Peer-reviewed veterinary case report
Copper-associated hepatitis in dogs diagnosed by liver biopsy
By Anthony Rodrigues et al.·Published in Open Veterinary Journal·2020·Centre Hospitalier Vétérinaire Frégis, Arcueil, France, LY·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Canine copper-associated hepatitis: A retrospective study of 17 clinical cases
- Species:
- dog
Plain-English summary
A group of 17 dogs, including Terriers and German Shepherds, were diagnosed with copper-associated hepatitis, a liver disease that can cause increased liver enzymes without obvious symptoms. Many of these dogs were around 8 years old, and some were diagnosed incidentally during routine check-ups. Liver biopsies confirmed the condition, showing different patterns of copper accumulation in the liver. Treatment details weren't specified, but early detection and monitoring of liver enzymes are crucial for managing this disease.
People also search for: dog liver disease symptoms · copper hepatitis in dogs · increased liver enzymes in dogs · German Shepherd liver problems · Terrier liver disease treatment
Abstract
Background: Copper-associated hepatitis (CAH) is a well-documented chronic hepatic disease in dogs. In some breeds, the disease results from an inherited defect in copper metabolism. In others, it is unclear whether its acummulation is a primary or secondary condition. Reports of copper accumulation in dog breeds that are not genetically predisposed are increasing. Aim: Describe the epidemiology, clinical and laboratory findings, liver biopsy techniques and treatment response in dogs with CAH. Methods: A retrospective study was performed, drawing upon medical records from CAH dogs at a Veterinary Referral Hospital in Paris, France. The diagnosis of CAH had been confirmed in these patients by positive rhodanine staining of hepatic tissue obtained through biopsy. Medical records were mined for the following data: age at presentation, sex, breed, chief presenting complaints, abdominal ultrasound (US) findings and rhodanine staining pattern. Results: A total of 17 dogs were included in the study. Median age at presentation was 8 years old (4-11). No sex predisposition was found. Terriers (4/17) and German Shepherd Dogs (GSD, 3/17) were overrepresented. American Staffordshire Terriers and Beauceron had not previously appeared in case reports on CAH; two of each breed were identified in this study. Clinical signs of affected dogs were non-specific. An incidental identification of increased liver-enzymes was observed in 5/17 dogs. A heterogeneous, mottled liver was frequently described (5/17) on abdominal US. Liver biopsies were performed by ultrasound-guided percutaneous approach in 10/17 dogs, laparoscopy and laparotomy in 6/17 and 1/17, respectively. The rhodanine staining pattern was centrilobular (zone 3) in 8/17 dogs and periportal (zone 1) in 3/17 dogs. The pattern was considered multifocal in 6/17 dogs. Conclusion: Increased liver enzymes may be the only clinical finding in dogs with copper-associated hepatitis, reflecting the silent progression of this disease. Centrilobular pattern of rhodanine staining was observed in the majority of cases suggesting the primary condition of the disease. Results of this study are consistent with the current literature, which reports that terriers and GSD are predisposed to CAH. This is the first description of CAH in Beauceron and American Staffordshire Terrier dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/http://dx.doi.org/10.4314/ovj.v10i2.2